UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Volltextzugriff (PDF)

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

JNCI : Journal of the National Cancer Institute, 2013-02, Vol.105 (3), p.175-201

2013

Volltextzugriff (PDF)

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Journal of adolescent health, 2009, Vol.44 (1), p.33-40

2009

Volltextzugriff (PDF)

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.926-935

2009

Volltextzugriff (PDF)

Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases

The American journal of surgical pathology, 2022-06, Vol.46 (6), p.765-773

2022

Volltextzugriff (PDF)

Preparation and standardization of Human papillomavirus (HPV) (Genotype 6) Nosode: Human papillomavirus (HPV) (Genotype 6) Nosode

International journal of high dilution research, 2021-04, Vol.18 (3-4), p.13-18

Shah, Rajesh

2021

Volltextzugriff (PDF)

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.936-944

2009

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Patterns and Disparities in Human Papillomavirus (HPV) Vaccine Uptake for Young Female Adolescents among U.S. States: NIS-Teen (2008-2016)

Cancer epidemiology, biomarkers & prevention, 2020-07, Vol.29 (7), p.1458-1467

2020

Volltextzugriff (PDF)

Provider Recommendation Mediates the Relationship Between Parental Human Papillomavirus (HPV) Vaccine Awareness and HPV Vaccine Initiation and Completion Among 13- to 17-Year-Old US Adolescent Children

Clinical pediatrics, 2015-04, Vol.54 (4), p.371-375

2015

Volltextzugriff (PDF)

The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer

Current opinion in virology, 2021-12, Vol.51, p.111-118

2021

Volltextzugriff (PDF)

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries

The Lancet regional health. Western Pacific, 2023-10, Vol.39, p.100860-100860, Article 100860

2023

Volltextzugriff (PDF)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report, 2015-03, Vol.64 (11), p.300-304

2015

Volltextzugriff (PDF)

Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule

Canada communicable disease report, 2016-07, Vol.42 (7), p.149-151

2016

Volltextzugriff (PDF)

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Journal of marketing communications, 2023-07, Vol.29 (5), p.491-509

2023

Volltextzugriff (PDF)

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

The Journal of infectious diseases, 2010-02, Vol.201 (3), p.478-478

2010

Volltextzugriff (PDF)

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma

Biochemical journal, 2012-04, Vol.443 (2), p.339-353

2012

Volltextzugriff (PDF)

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.525

2015

Volltextzugriff (PDF)

'en_US': 'Papillomavirus phylogeny and its correlation with human papillomavirus (HPV) and animal - literature review', 'es_ES': 'Filogenia del virus del papiloma y su correlación con el virus del papiloma humano y animal (Human papillomavirus\xa0- VPH) - revisión de la literatura', 'pt_BR': 'Filogenia do papilomavírus e sua correlação com papilomavírus humano (Human papillomavirus – HPV) e animal - revisão de literatura'

PUBVET, 2022-02, Vol.1 (6-07)

Rachel Siqueira de Queiroz Simões Marins

2022

Volltextzugriff (PDF)

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

Drugs (New York, N.Y.), 2011-03, Vol.71 (4), p.465-488

2011

Volltextzugriff (PDF)

O44 Health sciences schools students knowledge about human papillomavirus (HPV)

European journal of public health, 2019-06, Vol.29 (Supplement_2)

2019

Volltextzugriff (PDF)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

BMC women's health, 2021-10, Vol.21 (1), p.354-6, Article 354

2021

Volltextzugriff (PDF)

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.713-725

2013

Volltextzugriff (PDF)

Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination

JNCI : Journal of the National Cancer Institute, 2013-02, Vol.105 (3), p.158-161

2013

Volltextzugriff (PDF)

A Case for Immunization of Human Papillomavirus (HPV) 6/11—Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma

The Journal of infectious diseases, 2014-05, Vol.209 (9), p.1307-1309

Shah, Keerti V.

2014

Volltextzugriff (PDF)

1 – 25 von 103.757

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Zeitschrift / SerieHuman Vaccines & Immunotherapeutics

SpracheFranzösisch

SprachePortugiesisch

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71.028)
Mit Volltextzugriff
(73.352)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(99.702)
Deutsch
(1.364)
Spanisch
(649)
Japanisch
(606)
Chinesisch
(567)
Koreanisch
(403)
Russisch
(215)
Türkisch
(182)
Polnisch
(144)
Italienisch
(86)
Serbian
(48)
Croatian
(45)
Niederländisch
(45)
Ungarisch
(42)
Tschechisch
(41)
Dänisch
(33)
Norwegisch
(32)
Bulgarisch
(31)
Schwedisch
(27)
Persisch
(22)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(53.412)
Life Sciences & Biomedicine
(49.739)
Humans
(34.752)
Human Papillomavirus
(33.756)
Cervical Cancer
(20.455)
Female
(20.097)
Oncology
(15.764)
Cancer
(13.530)
Vaccines
(12.411)
Tumors
(9.338)
Immunization
(8.056)
Infections
(7.673)
Papillomavirus Infections
(7.384)
Immunology
(7.273)
Health Aspects
(7.249)
Womens Health
(6.939)
Risk Factors
(6.865)
Biological And Medical Sciences
(6.579)
Male
(6.493)
Public Health
(6.446)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(47.331)
Ingenta
(40.237)
MEDLINE
(36.559)
IngentaConnect Journals
(20.453)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(18.129)
Nexis Uni
(12.946)
Elsevier ScienceDirect Journals Complete
(12.504)
Springer Online Journals
(11.959)
NUS Single-Journal Subscriptions
(11.083)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(8.999)
ProQuest Dissertations & Theses A&I
(6.522)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(5.200)
Ebook Central Perpetual and DDA
(4.274)
eBooks on EBSCOhost
(4.023)
Taylor & Francis Journals
(3.988)
Nature Journals
(3.274)
Taylor & Francis
(3.091)
JSTOR Complete Journals
(2.681)
SAGE Journals
(2.575)
Taylor & Francis Journals Complete
(2.536)
Wiley Online Library
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(1.925)
Vaccine
(1.693)
Pr Newswire
(1.373)
Cancers
(1.246)
International Journal Of Molecular Sciences
(799)
Vaccines
(761)
Cancer Research
(757)
Business Wire
(746)
Sexually Transmitted Infections
(691)
Journal Of Virology
(677)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases

Preparation and standardization of Human papillomavirus (HPV) (Genotype 6) Nosode: Human papillomavirus (HPV) (Genotype 6) Nosode

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Patterns and Disparities in Human Papillomavirus (HPV) Vaccine Uptake for Young Female Adolescents among U.S. States: NIS-Teen (2008-2016)

Provider Recommendation Mediates the Relationship Between Parental Human Papillomavirus (HPV) Vaccine Awareness and HPV Vaccine Initiation and Completion Among 13- to 17-Year-Old US Adolescent Children

The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

O44 Health sciences schools students knowledge about human papillomavirus (HPV)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination

A Case for Immunization of Human Papillomavirus (HPV) 6/11—Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma

Aktive Filter

Suchergebnisse filtern